CLINDAMYCIN PHOSPHATE | A061839 | PHARMACIA AND UPJOHN CO
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from DuPont Pharmaceuticals FDA-1989-P-0176 · 4 docket documents Du Pont Pharmaceuticals submitted this citizen petition on January 25, 1989, requesting that the FDA Commissioner rule that an Abbreviated New Drug Application is acceptable for clindamycin phosphate injection USP at 150 mg/mL in 50 mL and 100 mL polyvinyl chloride containers. The petitioner argued | Other | 2017-07-17 | Withdrawn | DuPont Pharmaceuticals |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.